Genzyme Spinning Off Surgical Division, Transferring NeuroCell In-House
This article was originally published in The Gray Sheet
Executive Summary
Genzyme General plans to spin off its surgical products business into a separately traded company by the third quarter of 1999 in order to accelerate growth in both businesses, the Cambridge, Massachusetts-based firm announced March 4 in reporting 1998 year-end results.